Quick Answer
Edwards Lifesciences Corp reported Net Income of $1.07 billion for fiscal year 2025.
Edwards Lifesciences Corp Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | $1.07B | -74.3% |
| 2024 | $4.17B | +197.7% |
| 2023 | $1.40B | -7.9% |
| 2022 | $1.52B | +1.3% |
| 2021 | $1.50B | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $291.10M | -90.5% | -12.6% |
| June 30, 2025 | $333.20M | -9.0% | -6.9% |
| March 31, 2025 | $358.00M | +1.7% | -88.3% |
| September 30, 2024 | $3.07B | +697.8% | +738.3% |
| June 30, 2024 | $366.30M | +19.3% | +4.1% |
| March 31, 2024 | $351.90M | +3.3% | -8.6% |
| September 30, 2023 | $384.90M | +12.1% | +25.3% |
| June 30, 2023 | $307.10M | -24.4% | -9.8% |
- Edwards Lifesciences Corp showed a decrease of -74.3% in Net Income compared to the prior fiscal year.
- Over the 2021–2025 period, Edwards Lifesciences Corp’s net income has declined by 28.6% (from $1.50 billion to $1.07 billion).
- The most recent figure is from Edwards Lifesciences Corp’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 25, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: